Younger patients often require repeat corneal crosslinking, study finds

Video
Conference|AAO

At the 2022 American Academy of Ophthalmology meeting, Dr Philip Dockery, MPH, presents, "Effectiveness of corneal crosslinking in young patients."

Related Videos
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Marjorie Rah, OD, PhD, FAAO
Dr Srijana Adhikari speaks about her research ahead of the ARVO meeting
David A Berntsen, OD, PhD, FAAO, discusses the BLINK2 study
Dr Richard Lindstrom, Chairman of Surface Ophthalmics and founder of Minnesota Eye Consultants, speaks about ASCRS
Related Content
Two eyeballs in two mirrors. Image created with Canva AI.

Keratometry and total keratometry values are similar in healthy eyes

May 8th 2024
Article

Astigmatic values differed between K and TK readings

Image by Jennifer Toomey/MJH Life Sciences using Adobe Firefly AI

Reconfiguring treatment goals for paediatric myopia around ocular development

May 8th 2024
Article

Considering ages and stages of myopia progression in a therapeutic timeline

A young girl undergoes an eye exam. Image credit: ©Alexis S/peopleimages.com – stock.adobe.com

ARVO 2024: Children with CVI experience lower vision-specific quality of life, study results indicate

May 6th 2024
Article

Investigators say children with cortical/cerebral visual impairment experience markedly lower vision-specific quality of life

A group of children run outside. Image credit: ©JackF – stock.adobe.com

ARVO 2024: CHAMP phase 3 trial shows myopia controlled by low-dose atropine 0.01% over 4-year course

May 5th 2024
Article

This study also investigated the development of myopia rebound when dosing was discontinued

R. V. Paul Chan, MD, trains eye teams on board the Orbis Flying Eye Hospital in 2013. (Image courtesy of Geoff Oliver Bugbee)

Global partnership targets ROP in premature infants

March 28th 2024
Article

An AI-supported telemedicine effort from Siloam Vision and Orbis International

A pair of eyeglasses melting. Generated with Canva AI.

An alternative approach to spectacle independence

March 22nd 2024
Article

Laser blended vision is a proven modality for presbyopia treatment, but its principles can be reproduced with EDOF IOLs

© 2024 MJH Life Sciences

All rights reserved.